Clinical Trials Browser

Phase 3 × INDUSTRY × vadimezan × Clear all

NCT00662597 2020-12-24

ATRACT-1

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung

NCT00738387 2020-12-24

ATTRACT-2

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung